Link Details
| ID: | 1849 |
| Title: | Allos Therapeutics Initiates Study Of PDX In Patients With Cutaneous T-Cell Lymphoma - http://www.medicalnewstoday.com/articles/79768.php |
| Pagerank: | N/A |
| Description: | Allos Therapeutics, Inc. (Nasdaq: ALTH) today announced the initiation of patient enrollment in a Phase 1, open-label, multi-center study of the Companys novel antifolate PDX (pralatrexate) with vitamin B12 and folic acid supplementation in patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL). [click link for full article] |
| Category: | |
| Link Owner: | |
| Date Added: | August 16, 2007 07:00:00 AM |
| Number Hits: | 0 |